Literature DB >> 21316237

Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors.

Baker Jawabrah Al-Hourani1, Sai Kiran Sharma, Jonathan Y Mane, Jack Tuszynski, Vickie Baracos, Torsten Kniess, Mavanur Suresh, Jens Pietzsch, Frank Wuest.   

Abstract

A series of 1,5-diaryl-substituted tetrazole derivatives was synthesized via conversion of readily available diaryl amides into corresponding imidoylchlorides followed by reaction with sodium azide. All compounds were evaluated by cyclooxygenase (COX) assays in vitro to determine COX-1 and COX-2 inhibitory potency and selectivity. Tetrazoles 3a-e showed IC(50) values ranging from 0.42 to 8.1 mM for COX-1 and 2.0 to 200 μM for COX-2. Most potent compound 3c (IC(50) (COX-2)=2.0 μM) was further used in molecular modeling docking studies.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316237     DOI: 10.1016/j.bmcl.2011.01.057

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Synthesis of peptidomimetics, δ- and ε-lactam tetrazoles.

Authors:  Steven Gunawan; Kristen Keck; Alex Laetsch; Christopher Hulme
Journal:  Mol Divers       Date:  2012-05-24       Impact factor: 2.943

Review 2.  A review of syntheses of 1,5-disubstituted tetrazole derivatives.

Authors:  Afshin Sarvary; Ali Maleki
Journal:  Mol Divers       Date:  2014-10-02       Impact factor: 2.943

3.  Molecular docking and pharmacological/toxicological assessment of a new compound designed from celecoxib and paracetamol by molecular hybridization.

Authors:  Daiany P B da Silva; Iziara F Florentino; Dayane M da Silva; Roberta C Lino; Carina S Cardoso; Lorrane K S Moreira; Géssica A Vasconcelos; Daniela C Vinhal; Anna C D Cardoso; Bianca Villavicencio; Hugo Verli; Boniek G Vaz; Luciano M Lião; Luiz C da Cunha; Ricardo Menegatti; Elson A Costa
Journal:  Inflammopharmacology       Date:  2018-07-23       Impact factor: 4.473

Review 4.  Tetrazoles via Multicomponent Reactions.

Authors:  Constantinos G Neochoritis; Ting Zhao; Alexander Dömling
Journal:  Chem Rev       Date:  2019-02-01       Impact factor: 60.622

5.  Discovery of new non-acidic lonazolac analogues with COX-2 selectivity as potent anti-inflammatory agents.

Authors:  Marwa F Harras; Rehab Sabour; Omkulthom Mohamed Alkamali
Journal:  Medchemcomm       Date:  2019-07-22       Impact factor: 3.597

6.  Anti-inflammatory activity of novel thiosemicarbazone compounds indole-based as COX inhibitors.

Authors:  Íris T T Jacob; Fabiana O S Gomes; Mirelly D S de Miranda; Sinara M V de Almeida; Iranildo J da Cruz-Filho; Christina A Peixoto; Teresinha G da Silva; Diogo R M Moreira; Cristiane M L de Melo; Jamerson F de Oliveira; Maria C A de Lima
Journal:  Pharmacol Rep       Date:  2021-02-15       Impact factor: 3.024

7.  Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights.

Authors:  Chanchal Sonkar; Novina Malviya; Nilima Sinha; Attreyee Mukherjee; Srimanta Pakhira; Suman Mukhopadhyay
Journal:  Biometals       Date:  2021-04-26       Impact factor: 2.949

8.  Cyclooxygenase-1-selective inhibitors based on the (E)-2'-des-methyl-sulindac sulfide scaffold.

Authors:  Andy J Liedtke; Brenda C Crews; Cristina M Daniel; Anna L Blobaum; Philip J Kingsley; Kebreab Ghebreselasie; Lawrence J Marnett
Journal:  J Med Chem       Date:  2012-02-14       Impact factor: 7.446

Review 9.  Isocyanide-based multicomponent reactions towards cyclic constrained peptidomimetics.

Authors:  Gijs Koopmanschap; Eelco Ruijter; Romano Va Orru
Journal:  Beilstein J Org Chem       Date:  2014-03-04       Impact factor: 2.883

10.  3-(4-Bromo-phen-yl)-1-butyl-5-[1-(2-chloro-6-methyl-phen-yl)-1H-tetra-zol-5-yl]imidazolidine-2,4-dione.

Authors:  Gabriel B Hall; Federico Medda; Sue A Roberts; Christopher Hulme
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.